Company profile
LianBio CIK 1831283
Industry
Pharmaceutical Preparations
Headquarters
Princeton, NJ 08540
Fiscal year end
2022 (FY)
Key Financials
Revenue
—
Net income
-$110.29M
Total assets
$319.96M
Total liabilities
$26.31M
Stockholders' equity
$259.87M
Cash & equivalents
$79.22M
Operating income
-$125.35M
Operating cash flow
-$99.19M
Capital expenditures
$1.85M
Fiscal year 2022, via 10-K filed 2023-03-28. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$101.03M
Free cash flow margin
—
Liabilities / assets
8.2%
Equity / assets
81.2%
CapEx / revenue
—
Operating cash flow / net income
0.90×
Derived from the fiscal year 2022 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2022
—
-$110.29M
$319.96M
$26.31M
$259.87M
2021
—
-$196.30M
$426.34M
$39.01M
$353.56M
2020
—
-$139.60M
$279.29M
$27.57M
-$132.84M
Company Details
SIC code
2834
State of incorporation
E9
Active filer
Yes
Most recent SEC filing
Form SC 13G
2024-11-14
Financials filed via
Form 10-K
filed 2023-03-28
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Princeton, NJ 08540
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.